Terms: = Prostate cancer AND ALK, CD246, ENSG00000171094, 238, Q9UM73, TFG/ALK AND Staging
9 results:
1. Incidental findings on staging rectal MRI: clinical significance and outcomes.
Tang YZ; Alabousi A
Acta Radiol; 2024 Apr; 65(4):374-382. PubMed ID: 38115675
[TBL] [Abstract] [Full Text] [Related]
2. Rational use of Ga-68 PSMA PET-CT according to nomograms and risk groups for the detection of lymph node metastasis in prostate cancer.
Madendere S; Kılıç M; Köseoğlu E; Aykanat İC; Eden AB; Coşkun B; Tekkalan FB; Balbay MD
Urol Oncol; 2024 Feb; 42(2):29.e9-29.e15. PubMed ID: 38114351
[TBL] [Abstract] [Full Text] [Related]
3. cancer diagnoses and survival rise as 65-year-olds become Medicare-eligible.
Patel DC; He H; Berry MF; Yang CJ; Trope WL; Wang Y; Lui NS; Liou DZ; Backhus LM; Shrager JB
Cancer; 2021 Jul; 127(13):2302-2310. PubMed ID: 33778953
[TBL] [Abstract] [Full Text] [Related]
4. Prospective study on the effect of short-term androgen deprivation therapy on PSMA uptake evaluated with
Ettala O; Malaspina S; Tuokkola T; Luoto P; Löyttyniemi E; Boström PJ; Kemppainen J
Eur J Nucl Med Mol Imaging; 2020 Mar; 47(3):665-673. PubMed ID: 31879814
[TBL] [Abstract] [Full Text] [Related]
5. Impact of peri-prostatic fat measurements using MRI on the prediction of prostate cancer with transrectal ultrasound-guided biopsy.
Zhai TS; Jin L; Hu LT; Kadier A; Zhou Z; Liu X; Liu H; Li S; Lu JY; Yao XD; Ye L
Urol Oncol; 2020 Feb; 38(2):37.e1-37.e9. PubMed ID: 31812632
[TBL] [Abstract] [Full Text] [Related]
6. Prospective evaluation of plasma kinetic bipolar resection of bladder cancer: comparison to monopolar resection and pathologic findings.
Mashni J; Godoy G; Haarer C; Dalbagni G; Reuter VE; Al-Ahmadie H; Bochner BH
Int Urol Nephrol; 2014 Sep; 46(9):1699-705. PubMed ID: 24792236
[TBL] [Abstract] [Full Text] [Related]
7. IGF-II serum levels increase discrimination between benign prostatic hyperplasia and prostate cancer and improve the predictive value of PSA in clinical staging.
Trojan L; Bode C; Weiss C; Mayer D; Grobholz R; Alken P; Michel MS
Eur Urol; 2006 Feb; 49(2):286-92; discussion 292. PubMed ID: 16386354
[TBL] [Abstract] [Full Text] [Related]
8. Update on the appropriate staging evaluation for newly diagnosed prostate cancer.
O'Dowd GJ; Veltri RW; Orozco R; Miller MC; Oesterling JE
J Urol; 1997 Sep; 158(3 Pt 1):687-98. PubMed ID: 9258062
[TBL] [Abstract] [Full Text] [Related]
9. Serum prostate-specific antigen, clinical stage, pathologic grade, and the incidence of nodal metastases in prostate cancer.
Sands ME; Zagars GK; Pollack A; von Eschenbach AC
Urology; 1994 Aug; 44(2):215-20. PubMed ID: 7519381
[TBL] [Abstract] [Full Text] [Related]
